New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...
February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results